17 December 2020 - This second rate journalist thinks Zaltrap is listed on the PBS.
Cancer and heart disease are Australia’s biggest killers, but the medicine that’s costing taxpayers the most treats neither of these.
The medicine that cost taxpayers the most to subsidise last financial year was for the eye disease macular degeneration treatment Ablifercept sold under the brand names Eylea and Zaltrap.
Together these treatments cost the taxpayers more than $372.8 million in 2019-2020, a report for the government has revealed.